vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $20.4M, roughly 1.5× Sight Sciences, Inc.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -20.4%, a 11.8% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
FGI vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $20.4M |
| Net Profit | $-2.6M | $-4.2M |
| Gross Margin | 26.7% | 87.3% |
| Operating Margin | -2.2% | -18.0% |
| Net Margin | -8.6% | -20.4% |
| Revenue YoY | -14.4% | 6.9% |
| Net Profit YoY | -553.1% | 64.9% |
| EPS (diluted) | $-1.63 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $20.4M | ||
| Q3 25 | $35.8M | $19.9M | ||
| Q2 25 | $31.0M | $19.6M | ||
| Q1 25 | $33.2M | $17.5M | ||
| Q4 24 | $35.6M | $19.1M | ||
| Q3 24 | $36.1M | $20.2M | ||
| Q2 24 | $29.4M | $21.4M | ||
| Q1 24 | $30.8M | $19.3M |
| Q4 25 | $-2.6M | $-4.2M | ||
| Q3 25 | $-1.7M | $-8.2M | ||
| Q2 25 | $-1.2M | $-11.9M | ||
| Q1 25 | $-629.1K | $-14.2M | ||
| Q4 24 | $-402.3K | $-11.8M | ||
| Q3 24 | $-550.1K | $-11.1M | ||
| Q2 24 | $163.6K | $-12.3M | ||
| Q1 24 | $-412.2K | $-16.3M |
| Q4 25 | 26.7% | 87.3% | ||
| Q3 25 | 26.5% | 86.4% | ||
| Q2 25 | 28.1% | 84.8% | ||
| Q1 25 | 26.8% | 86.2% | ||
| Q4 24 | 24.6% | 86.8% | ||
| Q3 24 | 25.8% | 83.9% | ||
| Q2 24 | 30.5% | 85.8% | ||
| Q1 24 | 27.4% | 85.5% |
| Q4 25 | -2.2% | -18.0% | ||
| Q3 25 | 1.0% | -39.7% | ||
| Q2 25 | -2.7% | -59.6% | ||
| Q1 25 | -3.9% | -79.2% | ||
| Q4 24 | -3.5% | -62.5% | ||
| Q3 24 | -0.2% | -55.7% | ||
| Q2 24 | -1.5% | -59.2% | ||
| Q1 24 | -1.0% | -76.4% |
| Q4 25 | -8.6% | -20.4% | ||
| Q3 25 | -4.6% | -41.0% | ||
| Q2 25 | -4.0% | -61.0% | ||
| Q1 25 | -1.9% | -80.8% | ||
| Q4 24 | -1.1% | -62.1% | ||
| Q3 24 | -1.5% | -54.9% | ||
| Q2 24 | 0.6% | -57.7% | ||
| Q1 24 | -1.3% | -84.4% |
| Q4 25 | $-1.63 | $-0.07 | ||
| Q3 25 | $-0.86 | $-0.16 | ||
| Q2 25 | $-0.64 | $-0.23 | ||
| Q1 25 | $-0.07 | $-0.28 | ||
| Q4 24 | $-0.38 | $-0.23 | ||
| Q3 24 | $-0.29 | $-0.22 | ||
| Q2 24 | $0.08 | $-0.25 | ||
| Q1 24 | $-0.04 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $17.3M | $63.9M |
| Total Assets | $69.5M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $92.0M | ||
| Q3 25 | $1.9M | $92.4M | ||
| Q2 25 | $2.5M | $101.5M | ||
| Q1 25 | $1.2M | $108.8M | ||
| Q4 24 | $4.6M | $120.4M | ||
| Q3 24 | $3.0M | $118.6M | ||
| Q2 24 | $1.3M | $118.2M | ||
| Q1 24 | $3.3M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $17.3M | $63.9M | ||
| Q3 25 | $19.7M | $64.3M | ||
| Q2 25 | $21.3M | $70.0M | ||
| Q1 25 | $21.8M | $77.6M | ||
| Q4 24 | $22.3M | $87.5M | ||
| Q3 24 | $23.5M | $95.0M | ||
| Q2 24 | $23.8M | $101.6M | ||
| Q1 24 | $23.9M | $109.2M |
| Q4 25 | $69.5M | $115.3M | ||
| Q3 25 | $73.0M | $116.3M | ||
| Q2 25 | $71.7M | $122.0M | ||
| Q1 25 | $68.5M | $129.7M | ||
| Q4 24 | $75.5M | $142.8M | ||
| Q3 24 | $74.7M | $143.6M | ||
| Q2 24 | $69.9M | $149.7M | ||
| Q1 24 | $68.6M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-1.8M |
| Free Cash FlowOCF − Capex | $2.3M | $-2.0M |
| FCF MarginFCF / Revenue | 7.5% | -9.7% |
| Capex IntensityCapex / Revenue | 0.2% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-1.8M | ||
| Q3 25 | $-1.9M | $-8.7M | ||
| Q2 25 | $7.6M | $-7.5M | ||
| Q1 25 | $-7.4M | $-11.6M | ||
| Q4 24 | $617.4K | $-3.5M | ||
| Q3 24 | $-915.0K | $362.0K | ||
| Q2 24 | $862.1K | $-9.5M | ||
| Q1 24 | $-8.0M | $-9.8M |
| Q4 25 | $2.3M | $-2.0M | ||
| Q3 25 | $-2.1M | $-8.9M | ||
| Q2 25 | $7.4M | $-7.8M | ||
| Q1 25 | $-7.7M | — | ||
| Q4 24 | $-214.1K | $-3.6M | ||
| Q3 24 | $-1.1M | $311.0K | ||
| Q2 24 | $281.5K | $-9.5M | ||
| Q1 24 | $-8.6M | $-9.9M |
| Q4 25 | 7.5% | -9.7% | ||
| Q3 25 | -5.9% | -44.7% | ||
| Q2 25 | 23.8% | -39.6% | ||
| Q1 25 | -23.3% | — | ||
| Q4 24 | -0.6% | -18.9% | ||
| Q3 24 | -3.0% | 1.5% | ||
| Q2 24 | 1.0% | -44.7% | ||
| Q1 24 | -28.0% | -51.4% |
| Q4 25 | 0.2% | 0.8% | ||
| Q3 25 | 0.7% | 0.9% | ||
| Q2 25 | 0.7% | 1.1% | ||
| Q1 25 | 1.1% | 0.0% | ||
| Q4 24 | 2.3% | 0.7% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 2.0% | 0.4% | ||
| Q1 24 | 2.0% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
